Agraflora Organics International Inc (OTCMKTS:AGFAF) has disclosed the latest development regarding its subsidiary Farmako GmbH. The business guru says that Farmako will be free to engage in the distribution of medical cannabis flowers. These products have undergone the ionizing radiation treatment, and it seems great times lie ahead for this subsidiary.
The license and its impact
Agraflora has described the recent development as a major milestone for Farmako, saying that the German Federal Institute for Drugs and Medical Devices had done it a huge favor.
Reports indicate that the German medical cannabis marketplace has been encountering shortages in supply. A number of reasons have been cited to explain this undersupply, one of them being the scarcity of the EU-GMP certified cannabis flowers. What makes matters even worse is the fact that the exporting jurisdictions give tough conditions. One of them has been that one uses microbial sterilization before selling out products. Canada is one of these countries.
Eckmans and his perspective
The Chief Executive Officer of Farmako Katrin Eckmans says that it is a great achievement on their part to have secured the AMRadV license. He sees as a great stepping stone that will see them succeed in their quest to solve the major barriers that have been standing on their way to achieving massive business success.
Eckmans says that it feels great falling in the category of companies that can freely import and the sterilized cannabis flowers. The official believes that Farmako is on the right path, considering that it stands to benefit from the increased supply from various countries from around the globe.
The subsidiary is eyeing the significant growth in demand for the product and says that it will be taking full advantage of that.
Market observers say that Farmako stands to gain a huge deal from the German market. Reports indicate that the medical cannabis market in German may soon expand a great deal. It is projected that the expansion may get to the point of it becoming of the world’s biggest market places, focusing on the sale of cannabis products. Farmako says that it will uphold its efforts, which are targeted at making it more competitive as a licensed pharmaceutical wholesaler.